+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 30Years - 70Years
All Genders
ID07368699

Evaluation of Active Oxygen-Releasing Gel With Photodynamic Therapy Compared to Standard Scaling and Root Planing in Treating Stage III Periodontitis

Led by Alexandria University · Updated on 2026-10-09

42

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Stage III periodontitis is a serious gum disease that damages the tissues supporting teeth. This trial evaluates whether adding an active oxygen-releasing gel, with or without photodynamic therapy, improves treatment results compared to standard care alone. Researchers aim to better control inflammation and harmful bacteria beyond what scaling and root planing SRP can achieve. The study involves three groups of 42 patients with stage III periodontitis. One group receives SRP plus the oxygen-releasing gel applied to the gums for three minutes. A second group receives SRP, the gel, and antimicrobial photodynamic therapy using a diode laser with a special dye to target bacteria. The third group receives SRP alone using ultrasonic and manual tools. Participants gum health will be monitored by measuring gingival index, bleeding on probing, pocket depth, and attachment levels at the start and after one and three months. Microbiological samples will be taken to measure specific bacterial levels related to periodontitis. The study includes random assignment to groups and single masking, with assessments to track changes in clinical and bacterial outcomes.

CONDITIONS

Brief Title

Active Oxygen Releasing Gel With Photodynamic Therapy in Treating Stage III Periodontitis

Research Team

A

Aya Abdelmawla, BDS

A

Aliaa Gamaleldin Aboulela, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here